Neurostimulation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global neurostimulation devices market is on track to achieve remarkable growth, with a projected double-digit CAGR expected by the end of 2031. The market's expansion is fueled by the increasing awareness of mental health, technological innovations enhancing patient management, and novel technologies that restore vision and aid movement in paralysis cases.

Navigating Challenges Amidst the Pandemic

The COVID-19 pandemic initially impacted the demand for neurostimulation devices, resulting in a temporary decline in market revenue. However, as movement restrictions are relaxed across different nations, the market is anticipated to regain its growth momentum.

European Market Poised for Growth

The European neurostimulation devices market is expected to witness significant growth during the forecast period, driven by a growing preference for advanced technologies and innovations in the region. Meanwhile, the Asia Pacific presents lucrative growth opportunities for companies in the neurostimulation devices market. Market players are leveraging strategies such as collaborations and product innovations, harnessing the latest technologies to enrich their product portfolios. Key industry players include NeuroSigma, Inc., Boston Scientific Corporation, NDI Medical, LLC., Medtronic plc, and St. Jude Medical, Inc.

Addressing Neurological Disorders with Innovation

Neurostimulation devices play a vital role in diagnosing and treating disorders of the autonomic nervous system (ANS), central nervous system (CNS), and peripheral nervous system (PNS). These devices stimulate brain cells and facilitate medication administration, making them essential for managing chronic neurological conditions such as nociceptive pain, neuropathic pain, epilepsy, depression, and Parkinson's disease.

Market Dynamics

The global neurostimulation devices market is driven by increasing incidences of neurological diseases and the prevalence of associated chronic pain and discomfort. Factors such as a growing geriatric population, heightened awareness of improved neurological treatments, and advancements in neurostimulation device functionality are poised to shape market growth positively. However, challenges such as therapy-related side effects, treatment alternatives for neurological disorders, and associated risks may impede market expansion.

Segment Analysis

The market is segmented based on device type, application, and region. Device types include implantable and external devices. Implantable devices encompass cochlear implants, sacral nerve stimulation, gastric electric stimulation, deep brain stimulation, vagus nerve stimulation, and spinal cord stimulation. External devices comprise transcranial magnetic stimulation and transcutaneous electrical nerve stimulation. Applications include Parkinson's disease, epilepsy, urinary and fecal incontinence, gastroparesis, pain management, hearing loss, and depression.

Regional Insights

Geographically, the global neurostimulation devices market is categorized into North America, Asia Pacific, Europe, and the rest of the world (RoW). North America leads the market, driven by a rising prevalence of neurological disorders and extensive awareness campaigns by public and private organizations. Availability of advanced neurological treatments further bolsters the region's market growth.

In Europe, the neurostimulation devices market benefits from healthcare initiatives aimed at enhancing the healthcare sector. The Asia Pacific region is expected to witness the fastest growth, primarily due to increasing incidences of neurological disorders like arthritis and osteoporosis, particularly in countries like Japan and China.

The global neurostimulation devices market is poised for significant growth, with innovation and increasing awareness playing pivotal roles in addressing neurological disorders and improving patient outcomes.

1. Executive Summary

1.1. Global Neurostimulation Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Neurostimulation Devices Market Outlook, 2018 - 2031

3.1. Global Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Implantable device
  - 3.1.1.2. External devices
3.2. Global Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Spinal Cord Stimulation
  - 3.2.1.2. Deep Brain Stimulation
  - 3.2.1.3. Sacral Nerve Stimulation
  - 3.2.1.4. Vagus Nerve Stimulation
  - 3.2.1.5. Cochlear Implants
  - 3.2.1.6. Gastric Electric Stimulation
3.3. Global Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Transcutaneous Electrical Nerve Stimulation
  - 3.3.1.2. Transcranial Magnetic Stimulation
3.4. Global Neurostimulation Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Pain Management
  - 3.4.1.2. Parkinson's Disease
  - 3.4.1.3. Urinary and Fecal Incontinence
  - 3.4.1.4. Epilepsy
  - 3.4.1.5. Hearing loss
  - 3.4.1.6. Gastroparesis
  - 3.4.1.7. Depression
3.5. Global Neurostimulation Devices Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Neurostimulation Devices Market Outlook, 2018 - 2031

4.1. North America Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Implantable device
  - 4.1.1.2. External devices
4.2. North America Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Spinal Cord Stimulation
  - 4.2.1.2. Deep Brain Stimulation
  - 4.2.1.3. Sacral Nerve Strimulation
  - 4.2.1.4. Vagus Nerve Stimulation
  - 4.2.1.5. Cochlear Implants
  - 4.2.1.6. Gastric Electric Stimulation
4.3. North America Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Transcutaneous Electrical Nerve Stimulation
  - 4.3.1.2. Transcranial Magnetic Stimulation
4.4. North America Neurostimulation Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Pain Management
  - 4.4.1.2. Parkinson's Disease
  - 4.4.1.3. Urinary and Fecal Incontinence
  - 4.4.1.4. Epilepsy
  - 4.4.1.5. Hearing loss
  - 4.4.1.6. Gastroparesis
  - 4.4.1.7. Depression
4.5. North America Neurostimulation Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.2. U.S. Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 4.5.1.3. U.S. Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 4.5.1.4. U.S. Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.5. Canada Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.6. Canada Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 4.5.1.7. Canada Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 4.5.1.8. Canada Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Neurostimulation Devices Market Outlook, 2018 - 2031

5.1. Europe Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Implantable device
  - 5.1.1.2. External devices
5.2. Europe Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Spinal Cord Stimulation
  - 5.2.1.2. Deep Brain Stimulation
  - 5.2.1.3. Sacral Nerve Stimulation
  - 5.2.1.4. Vagus Nerve Stimulation
  - 5.2.1.5. Cochlear Implants
  - 5.2.1.6. Gastric Electric Stimulation
5.3. Europe Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Transcutaneous Electrical Nerve Stimulation
  - 5.3.1.2. Transcranial Magnetic Stimulation
5.4. Europe Neurostimulation Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Pain Management
  - 5.4.1.2. Parkinson's Disease
  - 5.4.1.3. Urinary and Fecal Incontinence
  - 5.4.1.4. Epilepsy
  - 5.4.1.5. Hearing loss
  - 5.4.1.6. Gastroparesis
  - 5.4.1.7. Depression
5.5. Europe Neurostimulation Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.2. Germany Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.3. Germany Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.4. Germany Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.5. U.K. Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.6. U.K. Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.7. U.K. Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.8. U.K. Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.9. France Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.10. France Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.11. France Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.12. France Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.13. Italy Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.14. Italy Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.15. Italy Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.16. Italy Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.17. Turkey Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.18. Turkey Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.19. Turkey Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.20. Turkey Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.21. Russia Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.22. Russia Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.23. Russia Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.24. Russia Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Neurostimulation Devices Market Outlook, 2018 - 2031

6.1. Asia Pacific Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Implantable device
  - 6.1.1.2. External devices
6.2. Asia Pacific Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Spinal Cord Stimulation
  - 6.2.1.2. Deep Brain Stimulation
  - 6.2.1.3. Sacral Nerve Stimulation
  - 6.2.1.4. Vagus Nerve Stimulation
  - 6.2.1.5. Cochlear Implants
  - 6.2.1.6. Gastric Electric Stimulation
6.3. Asia Pacific Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Transcutaneous Electrical Nerve Stimulation
  - 6.3.1.2. Transcranial Magnetic Stimulation
6.4. Asia Pacific Neurostimulation Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Pain Management
  - 6.4.1.2. Parkinson's Disease
  - 6.4.1.3. Urinary and Fecal Incontinence
  - 6.4.1.4. Epilepsy
  - 6.4.1.5. Hearing loss
  - 6.4.1.6. Gastroparesis
  - 6.4.1.7. Depression
6.5. Asia Pacific Neurostimulation Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.2. China Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.3. China Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.4. China Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.5. Japan Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.6. Japan Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.7. Japan Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.8. Japan Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.9. South Korea Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.10. South Korea Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.11. South Korea Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.12. South Korea Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.13. India Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.14. India Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.15. India Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.16. India Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Neurostimulation Devices Market Outlook, 2018 - 2031

7.1. Latin America Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Implantable device
  - 7.1.1.2. External devices
7.2. Latin America Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Bn), 2018 - 2031
7.3. Latin America Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Transcutaneous Electrical Nerve Stimulation
  - 7.3.1.2. Transcranial Magnetic Stimulation
7.4. Latin America Neurostimulation Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Pain Management
  - 7.4.1.2. Parkinson's Disease
  - 7.4.1.3. Urinary and Fecal Incontinence
  - 7.4.1.4. Epilepsy
  - 7.4.1.5. Hearing loss
  - 7.4.1.6. Gastroparesis
  - 7.4.1.7. Depression
7.5. Latin America Neurostimulation Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.2. Brazil Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 7.5.1.3. Brazil Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 7.5.1.4. Brazil Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.5. Mexico Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.6. Mexico Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 7.5.1.7. Mexico Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 7.5.1.8. Mexico Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.9. Argentina Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.10. Argentina Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 7.5.1.11. Argentina Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 7.5.1.12. Argentina Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Neurostimulation Devices Market Outlook, 2018 - 2031

8.1. Middle East & Africa Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Implantable device
  - 8.1.1.2. External devices
8.2. Middle East & Africa Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Spinal Cord Stimulation
  - 8.2.1.2. Deep Brain Stimulation
  - 8.2.1.3. Sacral Nerve Stimulation
  - 8.2.1.4. Vagus Nerve Stimulation
  - 8.2.1.5. Cochlear Implants
  - 8.2.1.6. Gastric Electric Stimulation
8.3. Middle East & Africa Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Transcutaneous Electrical Nerve Stimulation
  - 8.3.1.2. Transcranial Magnetic Stimulation
8.4. Middle East & Africa Neurostimulation Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Pain Management
  - 8.4.1.2. Parkinson's Disease
  - 8.4.1.3. Urinary and Fecal Incontinence
  - 8.4.1.4. Epilepsy
  - 8.4.1.5. Hearing loss
  - 8.4.1.6. Gastroparesis
  - 8.4.1.7. Depression
8.5. Middle East & Africa Neurostimulation Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.2. GCC Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.3. GCC Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.4. GCC Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.5. South Africa Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.6. South Africa Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.7. South Africa Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.8. South Africa Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.9. Egypt Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.10. Egypt Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.11. Egypt Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.12. Egypt Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.13. Nigeria Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.14. Nigeria Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.15. Nigeria Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.16. Nigeria Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Neurostimulation Devices Market by Device Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Neurostimulation Devices Market by Implantable Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Neurostimulation Devices Market by External Devices, Value (US$ Bn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Neurostimulation Devices Market by Application, Value (US$ Bn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By External Devices vs By Implantable Devices Heatmap
9.2. Manufacturer vs By Implantable Devices Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Medtronic plc
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. St. Jude Medical, Inc.
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Boston Scientific Corporation
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Cyberonics, Inc.
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Cochlear, Ltd.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. NeuroPace, Inc.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. NeuroSigma, Inc.
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. NDI Medical, LLC
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. MED-EL
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations